Source:http://linkedlifedata.com/resource/pubmed/id/10358752
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1999-8-31
|
pubmed:abstractText |
Interleukin-15 (IL-15) is a 14- to 15-kDa member of the 4 alpha-helix bundle family of cytokines. IL-15 expression is controlled at the levels of transcription, translation, and intracellular trafficking. In particular, IL-15 protein is posttranscriptionally regulated by multiple controlling elements that impede translation, including 12 upstream AUGs of the 5' UTR, 2 unusual signal peptides, and the C-terminus of the mature protein. IL-15 uses two distinct receptor and signaling pathways. In T and NK cells the IL-15 receptor includes IL-2/15R beta and gamma c subunits, which are shared with IL-2, and an IL-15-specific receptor subunit, IL-15R alpha. Mast cells respond to IL-15 with a receptor system that does not share elements with the IL-2 receptor but uses a novel 60- to 65-kDa IL-15RX subunit. In mast cells IL-15 signaling involves Jak2/STAT5 activation rather than the Jak1/Jak3 and STAT5/STAT3 system used in activated T cells. In addition to its other functional activities in immune and nonimmune cells, IL-15 plays a pivotal role in the development, survival, and function of NK cells. Abnormalities of IL-15 expression have been described in patients with rheumatoid arthritis or inflammatory bowel disease and in diseases associated with the retroviruses HIV and HTLV-I. New approaches directed toward IL-15, its receptor, or its signaling pathway may be of value in the therapy of these disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Complementary,
http://linkedlifedata.com/resource/pubmed/chemical/IL15RA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0732-0582
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-49
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10358752-Animals,
pubmed-meshheading:10358752-Autoimmune Diseases,
pubmed-meshheading:10358752-Base Sequence,
pubmed-meshheading:10358752-Cell Differentiation,
pubmed-meshheading:10358752-DNA, Complementary,
pubmed-meshheading:10358752-Gene Expression Regulation,
pubmed-meshheading:10358752-Humans,
pubmed-meshheading:10358752-Immunosuppression,
pubmed-meshheading:10358752-Immunotherapy,
pubmed-meshheading:10358752-Inflammation,
pubmed-meshheading:10358752-Interleukin-15,
pubmed-meshheading:10358752-Killer Cells, Natural,
pubmed-meshheading:10358752-Neoplasms,
pubmed-meshheading:10358752-Receptors, Interleukin-15,
pubmed-meshheading:10358752-Receptors, Interleukin-2,
pubmed-meshheading:10358752-Retroviridae Infections,
pubmed-meshheading:10358752-Signal Transduction
|
pubmed:year |
1999
|
pubmed:articleTitle |
The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.
|
pubmed:affiliation |
Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. tawald@helix.nih.gov
|
pubmed:publicationType |
Journal Article,
Review
|